Jeffrey Tornheim, MD, MPH

Titles:

Assistant Professor, Infectious Diseases, School of Medicine

SciVal:

SciVal Link

Jeff Tornheim, MD, MPH, is Assistant Professor in the Division of Infectious Diseases here at Johns Hopkins University School of Medicine. His research explores the application of new diagnostic technologies to improved health outcomes in the treatment of drug resistant tuberculosis among both adult and pediatric patients in India.

 

Dr. Tornheim completed a clinical fellowship in Infectious Diseases at Johns Hopkins after a combined residency in both internal medicine and pediatrics at Yale University School of Medicine. He received a BA in International Development and Economics from Brandeis University before moving to East Africa to work on strengthening health systems for returning refugees to South Sudan. In addition, he worked with the Centers for Disease Control and Prevention (CDC) International Emerging Infections Program on the epidemiology of pneumonia and diarrhea in Western Kenya. He received an MD/MPH from Mount Sinai School of Medicine, with thesis work evaluating the impact of water policy on rates of pediatric diarrhea in Bolivia. At the same time he worked at the Bureau of TB Control for the Department of Health and Mental Hygiene and was actively engaged in the operations of an East Harlem free clinic. Before finishing medicine, he spent 2 years in rural Bolivia to establish and manage operations for a Chagas Disease treatment program through the Fogarty International Clinical Scholars Program. His interest in clinical outcomes for underserved populations led him to practice in physician training environments in Bolivia, Peru, South Sudan, Kenya, Uganda, Rwanda, South Africa, and the United States.

 

He currently works with Drs. Amita Gupta, Kelly Dooley, Petros Karakousis, Vidya Mave, Bob Bollinger from Johns Hopkins, and with Drs. Zarir Udwadia, Camilla Rodrigues, and Tester Ashavaid from the P.D. Hinduja National Hospital and Medical Research Centre in Mumbai, India. His primary research activities include the epidemiology and microbiology of multidrug resistant tuberculosis (MDR-TB) in India, the use of whole genome sequencing as a tool to predict drug resistance and assess strain-relatedness for MDR-TB, and biomarkers of TB diagnosis and response to TB treatment.

Categories

Events

«

April 2020

»
S
M
T
W
T
F
S
·
·
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
·
·

Projects

A Blueprint for Success: Understanding the...

We are using a combination of statistical analysis and transmission modeling, in collaboration with the NYC Dept of Health &...

Read More

Comparative Effectiveness/Implementation of...

This cluster-randomized trial in 56 rural primary care clinics compares the effectiveness and implementation of three strategies...

Read More

A Comprehensive Snapshot of Tuberculosis...

This study aims to find all cases of TB within an urban Ugandan community of 50,000 people and to characterize both the...

Read More

Assessing the social value of novel regimens...

We are collaborating with investigators from the Berman Bioethics Institute to develop novel techniques for economic evaluation...

Read More

Scale-up and implementation of TB diagnostics...

We are evaluating the implementation, cost-effectiveness, and potential epidemiological impact of scaling up Xpert across 19...

Read More